Mirae Asset Global Investments’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.5K Sell
1,451
-205
-12% -$7K ﹤0.01% 1350
2026
Q1
$54.8K Buy
1,656
+120
+8% +$5.08K ﹤0.01% 1276
2025
Q4
$71.1K Buy
1,536
+318
+26% +$13.3K ﹤0.01% 1327
2025
Q3
$42.6K Sell
1,218
-24
-2% -$834 ﹤0.01% 1377
2025
Q2
$36.7K Buy
1,242
+186
+18% +$5.3K ﹤0.01% 1302
2025
Q1
$31.4K Sell
1,056
-19
-2% -$581 ﹤0.01% 1321
2024
Q4
$31.3K Sell
1,075
-90
-8% -$2.98K ﹤0.01% 1343
2024
Q3
$44.6K Buy
1,165
+188
+19% +$6.71K ﹤0.01% 1323
2024
Q2
$31.7K Sell
977
-15,001
-94% -$520K ﹤0.01% 1323
2024
Q1
$400K Sell
15,978
-735
-4% -$25.7K ﹤0.01% 2000
2023
Q4
$514K Buy
16,713
+868
+5% +$21.7K ﹤0.01% 1953
2023
Q3
$354K Buy
15,845
+34
+0.2% +$775 ﹤0.01% 2061
2023
Q2
$340K Sell
15,811
-58
-0.4% -$1.32K ﹤0.01% 2126
2023
Q1
$381K Sell
15,869
-10
-0.1% -$265 ﹤0.01% 2059
2022
Q4
$368K Sell
15,879
-2
-0% -$40 ﹤0.01% 2051
2022
Q3
$255K Buy
15,881
+4,405
+38% +$77.7K ﹤0.01% 2233
2022
Q2
$203K Buy
+11,476
New +$193K ﹤0.01% 2143

Other funds holding COLL

Mirae Asset Global Investments's COLL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Collegium Pharmaceutical (COLL) stake by 12% in Q2 2026, selling an estimated $7K and leaving 1,451 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.

Mirae Asset Global Investments first reported a position in COLL in Q2 2022 and has held it in 17 quarters since. The position peaked at $514K in Q4 2023. 101 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Mirae Asset Global Investments held 1,451 shares of Collegium Pharmaceutical worth $52.5K as of Q2 2026.
  • Mirae Asset Global Investments sold 205 Collegium Pharmaceutical shares in Q2 2026, an estimated $7K.
  • Collegium Pharmaceutical made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1350 holding.
  • Mirae Asset Global Investments first reported a position in Collegium Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Collegium Pharmaceutical position peaked at $514K in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.